Aspira women's health announces transition of its chief scientific officer/chief operating officer

Austin, texas, aug. 09, 2023 (globe newswire) -- aspira women's health inc. (“aspira” or “the company”) (nasdaq: awh), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that ryan phan, ph.d., is stepping down as the company's chief scientific and operating officer effective september 15, 2023. dr phan is expected to remain as an advisor for the company to provide scientific and operational advice related to ongoing product development programs.
AWH Ratings Summary
AWH Quant Ranking